IMPORTANT SAFETY INFORMATION
Do not take AZILECT® (rasagiline tablets) if you are taking meperidine as it could result in a serious reaction such as coma or death. Also, do not take AZILECT with tramadol, methadone, propoxyphene, dextromethorphan, St. John’s wort, or cyclobenzaprine. You also should not take AZILECT with other monoamine oxidase inhibitors (MAOIs), as it could result in an unsafe rise in blood pressure. Read More Important Safety Information
If you or a loved one has been diagnosed with Parkinson's disease, you may be faced with making your first treatment decision.
Traditionally, many physicians have opted to delay initial therapy until symptoms became more severe in order to minimize the risk of developing certain other symptoms that may be associated with some Parkinson's medications. Because there are many more treatment options today, however, many experts recommend that treatment begin early in the disease, even at diagnosis.
Studies show that Parkinson's can progress rapidly in the early phase, which can negatively affect a person's lifestyle. One study showed patients experienced a significant decline in their lifestyle compared with those who received treatment in the early phase of the disease.
Early treatment may provide patients with functional benefits at the beginning of their illness.
Fortunately, there are several treatment options for early Parkinson's disease, including AZILECT. Learn more about the options you have for getting started on treatment early in your disease.
AZILECT® (rasagiline tablets) is indicated for the treatment of Parkinson’s disease (PD).